Keywords: akarx, mgi, close, akr-501, deal, firms, pharma

AkaRx and MGI close AKR-501 deal

Article | 22 October 2007

Print This

US firms AkaRx and MGI Pharma say that their previously-announced development and license agreement has become effective. The deal provides ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in